These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2097160)

  • 1. Aldosterone content in plasma, erythrocytes and skeletal muscles in Icenko-Cushing's syndrome.
    Yakovlev HM; Yakovlev VA; Trofimov VM; Shustov SB; Vavilov AG
    Exp Clin Endocrinol; 1990 Nov; 96(2):138-42. PubMed ID: 2097160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
    Mantero F; Armanini D; Boscaro M
    Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aldosterone response to metoclopramide in patients with Cushing's disease.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1993; 101(3):138-43. PubMed ID: 8223981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestation of adrenocorticotropin-determined plasma concentrations of mineralocorticoid hormones.
    Biglieri EG; Brust N; Chang B; Hirai J; Wajchenberg BL; Schambelan M
    Prog Biochem Pharmacol; 1980; 17():36-43. PubMed ID: 6259660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of the arterial hypertensive syndrome in Itsenko-Cushing disease].
    Komissarenko IV; Slavnov VN; Cheban AK; Iakovlev AA; Demchenko NP
    Probl Endokrinol (Mosk); 1982; 28(6):28-31. PubMed ID: 6296809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variations of the renin aldosterone system in Cushing's disease (author's transl)].
    Bricaire H; Thibonnier M; Hautecouverture M; Corvol P; Luton JP
    Nouv Presse Med; 1980 Mar; 9(14):1007-9. PubMed ID: 6988802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
    Zacharieva S; Matrosov P; Stoeva I; Kirilov G
    Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North].
    Iakovlev VA; Sokol LIu; Karlov VA
    Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic aspects of hypertension in Cushing's syndrome.
    Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H
    Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and pressor mechanisms during alcohol withdrawal.
    Potter JF; Bannan LT; Saunders JB; Ingram MC; Beevers DG
    J Hypertens Suppl; 1983 Dec; 1(2):97-9. PubMed ID: 6400122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered circadian plasma cortisol and aldosterone group rhythms in Cushing's syndrome versus obesity and health.
    Kreze A; Spirova E; Sánchez de la Peña S; Cugini P; Mikulecky M; Halberg E; Halberg F
    Prog Clin Biol Res; 1987; 227B():203-17. PubMed ID: 3628333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H; Wocial B; Skórka B; Chodakowska J; Nazar K; Chwalbińska-Moneta J
    Acta Physiol Pol; 1980; 31(6):631-5. PubMed ID: 7018172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.
    Zelinka T; Strauch B; Pecen L; Widimský J
    J Hum Hypertens; 2004 Feb; 18(2):107-11. PubMed ID: 14730325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and Cushing's disease].
    Luton JP; Vidal-Trecan G; Mouveroux F; Bricaire H
    Ann Med Interne (Paris); 1983; 134(3):203-8. PubMed ID: 6625411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome.
    Raj SR; Biaggioni I; Yamhure PC; Black BK; Paranjape SY; Byrne DW; Robertson D
    Circulation; 2005 Apr; 111(13):1574-82. PubMed ID: 15781744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte sodium-lithium countertransport: relationship with plasma renin activity, aldosterone and atrial natriuretic peptide in a population study.
    Strazzullo P; Cappuccio FP; Miller MA; Buckley MG; Sagnella GA; Trevisan M; Pagano E; MacGregor GA
    J Hum Hypertens; 1994 Mar; 8(3):199-204. PubMed ID: 8006920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.